Peter Wang

Peter Wang, PhD, is an Associate Professor at Washington University in St. Louis, affiliated with the School of Medicine and the Department of Neurology. He also holds a secondary appointment in Biostatistics under the Institute for Informatics, Data Science and Biostatistics (I2DB). His work focuses on advanced statistical methodologies in clinical trials.

Research Interests: Peter specializes in designing and analyzing clinical trials for Alzheimer's disease, particularly Dominantly Inherited Alzheimer's Disease. His research explores neurodegenerative disorders, biomarker development, and longitudinal data analysis. He contributes to innovative trial designs and statistical models for assessing disease progression.

Articles: His recent work includes studies on gantenerumab efficacy, disease progression trajectories, and novel endpoints for neurodegenerative trials. Key collaborations involve the Dominantly Inherited Alzheimer Network (DIAN) and Wolfram syndrome neurodegeneration research.

Scientific Contributions: With over 3101 citations and 68 research outputs, Peter's work spans clinical trial design, data science, and medical informatics. He is based at Washington University's Center for Biostatistics and Data Science (CBDS) and Institute of Clinical and Translational Sciences (ICTS).